Abstract
Creutzfeldt-Jakob Disease (CJD) belongs to a group of infectious diseases characterized by spongiform encephalitis, which also includes Kuru, Gerstmann-Straussler- Scheinker syndrome, and fatal familial insomnia. Amongst these, the most common is CJD (responsible for aproximately 85 per cent of all cases of spongiform encephalitis) with an anual incidence of 1-2 cases in the general population and 5 cases in people with ages 60-74 years. Even though it was described more than 50 years ago there is still no effective treatment, being invariably fatal. Life expectancy is only 1 year after diagnosis.
We describe the case of a 65 year old female patient, who was seen at our institution with a 1 year history of rapid decline of her mental function, initially manifest as behavioral changes followed by dementia and later by motor disfunction. During the last months she was bedridden and unable to communicate, which led her family to seek help in our institution. Clinical, neuropathological and imaging characteristics were compatible with sporadic Creutzfeldt-Jakob disease.
References
Prusiner, S. Shattuck lecture - Neurodegenerative Diseases and Prions. N Engl J Med 2001; 344: 1516-1526.
Eggenberger E. Prion Disease. Neurol Clin 2007 ;25: 833-842.
Sanchez-Juan P, Cousens S, Will R, van Duijn C. Source of Variant Creutzfeldt-Jakob Disease outside United Kingdom. Emerg Infect Dis 2007; 13: 1166-1169.
Manson J.C., Cancellotti E, Hart P, Bishop M.T., Barron R.M. The Transmissible Spongiform Encephalopathies: Emerging And Declining Epidemics. Biochem Soc Trans 2006; 34: 1155-1158.
Johnson R, Gibbs C. Creutzfeldt-Jakob Disease And Related Transmissible Spongiform Encephalopathies. N Engl J Med 1998; 339: 1994-2004
Goldbergh, A. On Prions, Proteasomes, and Mad Cows. N Engl J Med 2007; 357: 1150-1152
Kristiansen M, Deriziotis P, Dimcheff D, Jackson G, Ovaa H, Naumann H, et al. Disease-Associated Prion Protein Oligomers Inhibit the 26S Proteasome. Molecular Cell 2007; 26: 175-188.
Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of Sporadic Creutzfeldt- Jakob Disease Based on Molecular and Phenotypic Analysis of 300 Subjects. Ann Neurol 1999; 46: 224-233.
Castellani R.J., Colucci M, Xie Z, Zou W, Li C, Parchi P, et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 2004; 63: 436-442.
Zerr I, Schulz-Schaeffer W, Giese A, Bodemer M, Schroter A, Henkel K, et al. Current Clinical Diagnosis in Creutzfeldt-Jakob Disease: Identification of Uncommon Variants. Ann Neurol 2000; 48: 323-329.
Wieser H, Schindler K, Zumsteg D. EEG in Creutzfeldt-Jakob disease. Clin Neurophysiol 2006; 117: 935-951
ShigaY, Miyazawa K, Sato S, Fukushima R, Shibuya S, Sato Y, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology 2004; 63: 443-449.
Xin L, Lin M, Ning-yu A, You-quan C, Yan L, Xing- gao G. Diffusion-weighted magnetic resonance imaging in diagnosis of Creutzfeldt-Jakob disease. Chin Med J 2006; 119(15): 1242-1247.
Bahn M, Parchi P. Abnormal Diffusion-Weighted Magnetic Resonance Images In Creutzfeldt-Jakob Disease. Arch Neurol 1999; 56: 577-583.
Meissner B, Köhler K; Körtner K, Bartl M, Jastrow U, Mollenhauer B, et al. Sporadic Creutzfeldt-Jakob Disease: Magnetic Resonance Imaging And Clinical Findings. Neurology 2004; 63: 450-456.
Zanusso G, Ferrari S, Cardone F, Zampieri P, Gelati M, Fiorini M, et.al. Detection of Pathologic Prion Protein in the Olfactory Epithelium in Sporadic Creutzfeldt-Jakob Disease. N Engl J Med 2003; 348: 711-719.
du Plessis DG, Larner AJ. Phenotypic similarities causing clinical misdiagnosis of pathologically-confirmed sporadic Creutzfeldt-Jakob disease as dementia with Lewy bodies. Clin Neurol Neurosurg 2008; 110(2): 194-197.
Rossi G, Salmona M, Forloni G, Bugiani O, Tagliavini F. Therapeutic approaches to prion diseases. Clin Lab Med
; 23: 187-208.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.